Search

Search Constraints

You searched for: Author/Creator , Issue Volume 21:Issue 1(2020)

Search Results

1. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2020)

2. Carcinogenicity of some industrial chemical intermediates and solvents. Issue 1 (January 2020)

3. Five years of improving diabetes control in Czech children after the establishment of the population‐based childhood diabetes register ČENDA. Issue 1 (16th October 2019)

6. Post‐exposure prophylaxis for HIV infection in sexual assault victims. Issue 1 (11th October 2019)

7. Prevalence and management of drug–drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study. Issue 1 (18th September 2019)

8. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial. Issue 1 (January 2020)

9. Statement in response to calls for banning evidence-based supportive health interventions for transgender and gender diverse youth. Issue 1 (2nd January 2020)

10. Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination. Issue 1 (2nd January 2020)